{"schema_version":"secwatch.filing_event.v1","accession":"0001823239-22-000048","form_type":"8-K","ticker":"MRVI","cik":"0001823239","company_name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","filed_at":"2022-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.371849+00:00","generated_at":"2026-06-23T06:06:01.082895+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Maravai names Trey Martin CEO, co-founder Carl Hull becomes Executive Chairman","bullets":["Martin appointed CEO effective Sept 30, 2022, succeeding Carl Hull who becomes Executive Chairman.","Martin previously SVP at Danaher, President of Integrated DNA Technologies; over 25 yrs in life sciences.","Martin receives base salary $750k, target bonus $937.5k for 2022, and equity awards totaling ~$17M.","Hull's base salary reduced to $500k; target bonus for 2022 remains $725k, subsequent years 100% of base.","Company to discuss transition on Q3 2022 earnings call scheduled for Nov 2."],"urls":{"canonical":"https://secwatch.observer/filing/0001823239-22-000048","json":"https://secwatch.observer/filing/0001823239-22-000048.json","markdown":"https://secwatch.observer/filing/0001823239-22-000048.md","text":"https://secwatch.observer/filing/0001823239-22-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1823239/000182323922000048/0001823239-22-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1823239/000182323922000048/mrvi-20220930.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T06:06:01.082895+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6e99a7389e","claim":"William \"Trey\" Martin, III was appointed as Chief Executive Officer at MARAVAI LIFESCIENCES HOLDINGS, INC..","evidence_excerpt":"On September 30, 2022, William “Trey” Martin, III was appointed Chief Executive Officer of Maravai LifeSciences Holdings, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1823239/000182323922000048/0001823239-22-000048-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}